NCT01410201View on ClinicalTrials.gov

Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane

NATerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Epiretinal MembraneMacular Edema
Interventions
DRUG

Dexamethasone Intravitreal Implant

Half of the study participants (15 out of 30) will receive one - Dexamethasone Intravitreal Implant 0.7 mg.

Trial Locations (3)

63017

St. Lukes Hospital, Chesterfield

63131

St. Louis Eye Surgery and Laser Center, St Louis

63144

The Retina Institute, St Louis

Sponsors

Collaborators (1)

Allergan
All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

Barnes Retina Institute

OTHER